MEDINET Co., Ltd.

Tokyo Stock Exchange 2370.T

MEDINET Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending September 30, 2024: USD 10.16 M

MEDINET Co., Ltd. Net Cash Used Provided By Financing Activities is USD 10.16 M for the year ending September 30, 2024, a 31.19% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.

MEDINET Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending September 30, 2023 was USD 7.75 M, a -29.23% change year over year.
MEDINET Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending September 30, 2022 was USD 10.95 M, a 12.58% change year over year.
MEDINET Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending September 30, 2021 was USD 9.72 M, a -63.21% change year over year.
MEDINET Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending September 30, 2020 was USD 26.43 M, a 3,071.79% change year over year.

Key data

Date	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure	Effect Of Forex Changes On Cash

Tokyo Stock Exchange: 2370.T

MEDINET Co., Ltd.

CEO	Kanenao Kubushiro
IPO Date	Oct. 8, 2003
Location	Japan
Headquarters	TRC Center Building
Employees	92
Sector	Healthcare
Industries Biotechnology 3D Printing Medical Instruments Robotics

Description

MEDINET Co., Ltd. operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy solutions in Japan. Its solutions include technical know-how, facilities, systems, materials, professional cell-engineers, and other requirements to conduct immuno-cell therapy. The company also manufactures regenerative medical/investigational and specified cell products. In addition, its value chain solutions include personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management system, quality control and assurance, and technology transfer and process development solutions. Further, the company supports medical institutions, research institutions, and biopharmaceutical companies to conduct immuno-cell therapy. MEDINET Co., Ltd. was incorporated in 1995 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years